Floating Button
Home News Capital markets

Will glovemakers enjoy a Mpox-induced demand spike?

Khairani Afifi Noordin & Felicia Tan
Khairani Afifi Noordin & Felicia Tan • 7 min read
Will glovemakers enjoy a Mpox-induced demand spike?
Some regional publicly-listed glovemakers have experienced significant share price movements since the spread of the new strain. Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Just a few years after the Covid-19 pandemic, the world is on the brink of another global outbreak — monkeypox (Mpox), a virus which causes painful rashes, swollen lymph nodes and fever. Although the virus is not new, the World Health Organization (WHO) declared a public health emergency in mid-August due to the rapid spread of a new strain in Africa.

As the outbreak worsens, Asian countries, including major economies like China and India, have increased their surveillance and countermeasures, especially after Thailand reported its first suspected case of the new variant.

Unsurprisingly, some regional publicly-listed glovemakers have experienced significant share price movements since then. After the WHO’s announcement, Singapore Exchange (SGX:S68) (SGX)-listed companies like Top Glove, Riverstone, Sri Trang Gloves (SGX:STG) and UG Healthcare also saw their share prices rise. For instance, Sri Trang Gloves’ share price jumped 22.8% on Aug 21, closing at 43 cents, and is up 48% year-to-date.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.